Literature DB >> 10831802

Developmental study of immunocompetent cells in the bronchus-associated lymphoid tissue (BALT) from Wistar rats.

M G Márquez1, G A Sosa, M E Roux.   

Abstract

The aim of the present report was to study in growing Wistar rats the development of immunocompetent cells in the bronchus-associated lymphoid tissue (BALT). We found at day 4 postpartum, a high number of TCRgamma/delta+ T cells and very few CD8alpha+, CD8beta+, CD5+, TCRalpha/beta+ T cells in BALT. The latter cells and CD4+ T cells increase with age. Even though T cells expressing TCRgamma/delta outnumber those expressing TCRalpha/beta early in development, until 45 days of age, alpha/beta+ predominate over gamma/delta+ T cells only in adult rats (60 days of age). Moreover, a predominance of suppressor/cytotoxic T cells over T-helper cells was found in 60 days old rats. Surprisingly, more CD8alpha+ than CD8beta+ T cells in BALT are observed. The number of IgA+ B and CD4+ T cells found in the BALT increases with age. The early appearance - 4 days of age - of all T-cell phenotypes in BALT especially of gamma/delta+ T cells may imply a benefit to respond to inhaled antigen soon after birth.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10831802     DOI: 10.1016/s0145-305x(00)00003-3

Source DB:  PubMed          Journal:  Dev Comp Immunol        ISSN: 0145-305X            Impact factor:   3.636


  3 in total

1.  Role of lymphotoxin and homeostatic chemokines in the development and function of local lymphoid tissues in the respiratory tract.

Authors:  Javier Rangel-Moreno; Damian Carragher; Troy D Randall
Journal:  Inmunologia       Date:  2007

2.  Postnatal development of lung T lymphocytes in a porcine model.

Authors:  Angel J Balam-May; Carmen Ramírez-Estudillo; Gloria Lazo-Vázquez; Marco A Vega-López
Journal:  Lung       Date:  2014-07-17       Impact factor: 2.584

Review 3.  Manipulation of acute inflammatory lung disease.

Authors:  E L Wissinger; J Saldana; A Didierlaurent; T Hussell
Journal:  Mucosal Immunol       Date:  2008-05-07       Impact factor: 7.313

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.